Skip to main content

Table 1 Detailed schedule of assessments

From: Study protocol: a randomised controlled trial on the clinical effects of levothyroxine treatment for subclinical hypothyroidism in people aged 80 years and over

Months of follow up

0 visit

6-8 wks

6m

12m

18m

24m

30m

36m

Finala visit

visit

call/visit

visit

call/visit

visit

call/visit

visit

Participant characteristics & medical history

x

        

Weight, height, waist circumference and BMI

x

  

x

    

x

Concomitant medication

x

x

 

x

 

x

 

x

x

Home support

x

       

x

Safety and monitoring

Morbidity, mortality, hospitalisation and GP contacts

 

x

x

x

x

x

x

x

x

Serious Adverse Events

 

x

x

x

x

x

x

x

x

Single-lead ECG (for AF)

x

  

x

 

x

 

x

x

Drug adherence

 

x

x

x

x

x

x

x

x

Outcomes

Thyroid related quality of life (ThyPRO)

x

x

 

x

    

x

Generic quality of life (EQ-5D-3L)

x

x

 

x

    

x

Cognitive function

 MMSE

x

        

 Letter Digit Coding Test

x

       

x

Functional ability

 ADL (BI), IADL (OARS), falls questionnaire

x

       

x

 Handgrip strength & 6-meter gait speed

x

  

x

    

x

Blood pressure

x

  

x

    

x

Fatal and non-fatal cardiovascular events

 

x

x

x

x

x

x

x

x

Arthritis complaints

        

x

Treatment Satisfaction (TSQM vII)

        

x

Laboratory analysis

Thyroid function

x

x

 

x

 

x

 

x

x

Haemoglobin

x

  

x

     

Blood samples for biobank

x

  

x

     
  1. athe final visit assessments may substitute for any assessment time between 12 and a maximum of 42 months